Progestins and hemostasis;Gestagene und Hamostase

Zentralblatt fur Gynakologie

Volumn 119, Issue SUPPL. 2, 1997, Pages 17-19

  Schindler, A E ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Cancer; Hemostasis; Progesterone; Progestins

Indexed keywords

GESTAGEN; PROGESTERONE;

BLOOD CLOTTING; CANCER PATIENT; FIBRINOLYSIS; HEMOSTASIS; REVIEW; BLOOD; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; FEMALE; FEMALE GENITAL TRACT TUMOR; HUMAN; PHYSIOLOGY; RISK FACTOR; THROMBOEMBOLISM;

DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENITAL NEOPLASMS, FEMALE; HEMOSTASIS; HUMANS; PROGESTINS; RISK FACTORS; THROMBOEMBOLISM;

EID: 0030662634     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Aylward M: Coagulation factors in opposed and unopposed oestrogen treatment at the climacteric. Postgrad Med J 54 (1978) Suppl. 2, 31-37
2. Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S: Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 348 (1996) 977-980
3. Fahmy K, Khairy M, Allem G, Gobran F, Alloush M: Effect of depomedroxyprogesterone acetate on coagulation factors and serum Lipids in Egyptian women. Contraception 44 (1991) 431-444
4. Grodstein F, Stampfer MJ, Goldhaber SZ, Manson JE, Colditz GA, Speizer FE, Willett WC, Hennekens CH: Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 348 (1996) 983-987
5. Jick H, Derby LE, Myers MW, Vasilakis C, Newton KM: Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 348 (1996) 981-983
6. Kuhl H: Effects of progestogens on haemostasis. Maturitas 24 (1996) 1-19
7. Lewis MA, Heinemann LAJ, MacRae KD, Bruppacher R, Spitzer WO: The increased risk of venous thromboembolism and the use of third generation progestagens: Role of bias in observational research. Contraception 54 (1996) 5-13
8. Lira P, Rivera L, Diaz S, Croxatto HB: Study of blood coagulation in women treated with megestrol acetate implants. Contraception 12 (1975) 639-644
9. Miller ME, Thorpe SL, Dores GM: Influence of hormones on platelet intracellular calcium. Thromb Res 77 (1995) 515-530
10. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M: Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. New Engl J Med 328 (1993) 1069-1075
11. Norris LA, Bonnar J: The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives. Brit J Obstet Gynaecol 103 (1996) 261-267
12. Notelovitz M, Kitchens C, Ware M, Hirschberg K: Combination estrogen and progestogen replacement therapy does not adversely affect coagulation. Obstet Gynecol 62 (1983) 596-600
13. Oberhoff C, Winkler UH, Schindler AE: Hemostasis in women taking megestrol acetate for advanced gynecological cancer. J Canc Res Clin One 120 (1994) Suppl R42
14. Raman BB, Standley PR, Rajkumar V, Ram JL, Sowers JR: Effects of estradiol and progesterone on platelet calcium responses. Amer J Hypertension 8 (1995) 197-200
15. Schindler AE: Hemostasis and high-dose gestagen treatment in gynecological oncology. Gynecol Endocrinol 7 (1993) 99-103
16. Singh K, Viegas OAC, Koh SCL, Ratnam SS: Effect of Long-term use of Norplant implants on haemostatic function. Contraception 45 (1992) 203-219
17. Singh K, Viegas OAC, Koh SCL, Ratnam SS: Effect of Norplant-2 rods on haemostatic function. Contraception 46 (1992) 71-81
18. Winkler UH, Oberhoff C, Bier U, Schindler AE, Gillain D: Hemostatic effects of two oral contraceptives containing low doses of ethinyl estradiol and either gestodene or norgestimate: An open, randomized, parallel-group study. Int J Fertil 40 (1995) 260-268
19. Winkler UH: Hormone replacement therapy and hemostasis: principles of a complex interaction. Maturitas 24 (1996) 131-145